{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T22:43:18Z","timestamp":1790462598922,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Bundesministerium fuer Bildung und Forschung","award":["RAPID 01Kl1723C"],"award-info":[{"award-number":["RAPID 01Kl1723C"]}]},{"DOI":"10.13039\/100009139","name":"German Center for Infection Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009139","name":"DZIF","doi-asserted-by":"publisher","award":["TTU EI 01.806"],"award-info":[{"award-number":["TTU EI 01.806"]}],"id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008426","name":"Friedrich-Baur-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008426","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.antiviral.2019.104620","type":"journal-article","created":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T12:04:24Z","timestamp":1571400264000},"page":"104620","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"special_numbering":"C","title":["Influences of cyclosporin A and non-immunosuppressive derivatives on cellular cyclophilins and viral nucleocapsid protein during human coronavirus 229E replication"],"prefix":"10.1016","volume":"173","author":[{"given":"Yue","family":"Ma-Lauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslav","family":"Male\u0161evi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"von Brunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunter","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albrecht","family":"von Brunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2019.104620_bib1","doi-asserted-by":"crossref","first-page":"9739","DOI":"10.1073\/pnas.0504296102","article-title":"Efficient hepatitis C virus cell culture system: what a difference the host cell makes","volume":"102","author":"Bartenschlager","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2019.104620_bib2","doi-asserted-by":"crossref","first-page":"13001","DOI":"10.1128\/JVI.76.24.13001-13014.2002","article-title":"Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication","volume":"76","author":"Blight","year":"2002","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2019.104620_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2014.11.010","article-title":"A\u00a0screen of the NIH Clinical Collection small molecule library identifies potential anti-coronavirus drugs","volume":"114","author":"Cao","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.104620_bib4","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.virusres.2014.02.010","article-title":"Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including Alisporivir","volume":"184","author":"Carbajo-Lozoya","year":"2014","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2019.104620_bib5","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.virusres.2012.02.002","article-title":"Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506","volume":"165","author":"Carbajo-Lozoya","year":"2012","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2019.104620_bib6","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00171-10","article-title":"Dendritic cell-specific antigen delivery by coronavirus vaccine vectors induces long-lasting protective antiviral and antitumor immunity","volume":"1","author":"Cervantes-Barragan","year":"2010","journal-title":"mBio"},{"key":"10.1016\/j.antiviral.2019.104620_bib7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.antiviral.2013.12.009","article-title":"The SARS coronavirus nucleocapsid protein \u2013 forms and functions","volume":"103","author":"Chang","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.104620_bib8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/bs.aivir.2018.01.001","article-title":"Hosts and sources of endemic human coronaviruses","volume":"100","author":"Corman","year":"2018","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.antiviral.2019.104620_bib9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","article-title":"Origin and evolution of pathogenic coronaviruses","volume":"17","author":"Cui","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2019.104620_bib10","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0091-6749(96)70237-3","article-title":"Cyclosporin H is a potent and selective competitive antagonist of human basophil activation by N-formyl-methionyl-leucyl-phenylalanine","volume":"98","author":"de Paulis","year":"1996","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.antiviral.2019.104620_bib11","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1128\/AAC.03011-14","article-title":"Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture","volume":"58","author":"de Wilde","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2019.104620_bib12","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1128\/JVI.02078-12","article-title":"Cyclophilin inhibitors block Arterivirus replication by interfering with viral RNA synthesis","volume":"87","author":"de Wilde","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2019.104620_bib13","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1099\/vir.0.052910-0","article-title":"MERS-coronavirus replication induces severe in\u00a0vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-alpha treatment","volume":"94","author":"de Wilde","year":"2013","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.antiviral.2019.104620_bib14","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.virol.2017.11.022","article-title":"Coronaviruses and arteriviruses display striking differences in their cyclophilin A-dependence during replication in cell culture","volume":"517","author":"de Wilde","year":"2018","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2019.104620_bib15","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1099\/vir.0.034983-0","article-title":"Cyclosporin A inhibits the replication of diverse coronaviruses","volume":"92","author":"de Wilde","year":"2011","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.antiviral.2019.104620_bib16","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1128\/AAC.03036-14","article-title":"Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection","volume":"58","author":"Dyall","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2019.104620_bib17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1743-422X-7-44","article-title":"Increased susceptibility of Huh7 cells to HCV replication does not require mutations in RIG-I","volume":"7","author":"Feigelstock","year":"2010","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2019.104620_bib18","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10254-003-0011-3","article-title":"Regulation of peptide bond cis\/trans isomerization by enzyme catalysis and its implication in physiological processes","volume":"148","author":"Fischer","year":"2003","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.antiviral.2019.104620_bib19","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1128\/JVI.79.1.380-392.2005","article-title":"Kissing-loop interaction in the 3' end of the hepatitis C virus genome essential for RNA replication","volume":"79","author":"Friebe","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2019.104620_bib20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2147\/DDDT.S30946","article-title":"Profile of alisporivir and its potential in the treatment of hepatitis C","volume":"7","author":"Gallay","year":"2013","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.antiviral.2019.104620_bib21","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/j.bbagen.2014.11.011","article-title":"The role of immunophilins in viral infection","volume":"1850","author":"Hopkins","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.antiviral.2019.104620_bib22","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1128\/AAC.00660-09","article-title":"SCY-635, a novel nonimmunosuppressive analog of cyclosporine that exhibits potent inhibition of hepatitis C virus RNA replication in\u00a0vitro","volume":"54","author":"Hopkins","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2019.104620_bib23","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4161\/cbt.2.3.360","article-title":"Rapamycins: mechanism of action and cellular resistance","volume":"2","author":"Huang","year":"2003","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.antiviral.2019.104620_bib24","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1128\/JVI.01534-06","article-title":"The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells","volume":"81","author":"Koutsoudakis","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2019.104620_bib25","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1128\/AAC.03406-14","article-title":"Alternative screening approaches for discovery of Middle East respiratory syndrome coronavirus inhibitors","volume":"58","author":"LaFemina","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2019.104620_bib26","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/329268a0","article-title":"Catalysis of protein folding by prolyl isomerase","volume":"329","author":"Lang","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2019.104620_bib27","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1126\/science.3749892","article-title":"Does the binding of cyclosporine to calmodulin result in immunosuppression?","volume":"234","author":"LeGrue","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2019.104620_bib28","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.antiviral.2017.11.001","article-title":"Nsp3 of coronaviruses: structures and functions of a large multi-domain protein","volume":"149","author":"Lei","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.104620_bib29","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.antiviral.2013.03.020","article-title":"Curing a viral infection by targeting the host: the example of cyclophilin inhibitors","volume":"99","author":"Lin","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.104620_bib30","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.bbrc.2004.07.003","article-title":"Nucleocapsid protein of SARS coronavirus tightly binds to human cyclophilin A","volume":"321","author":"Luo","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2019.104620_bib31","doi-asserted-by":"crossref","first-page":"E5192","DOI":"10.1073\/pnas.1603435113","article-title":"p53 down-regulates SARS coronavirus replication and is targeted by the SARS-unique domain and PLpro via E3 ubiquitin ligase RCHY1","volume":"113","author":"Ma-Lauer","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.antiviral.2019.104620_bib32","doi-asserted-by":"crossref","first-page":"7302","DOI":"10.1021\/jm4007577","article-title":"Anti-inflammatory effects of extracellular cyclosporins are exclusively mediated by CD147","volume":"56","author":"Male\u0161evi\u0107","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.antiviral.2019.104620_bib33","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.3390\/v6082991","article-title":"The coronavirus nucleocapsid is a multifunctional protein","volume":"6","author":"McBride","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2019.104620_bib34","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.cld.2012.09.008","article-title":"Cyclophilin inhibitors for hepatitis C therapy","volume":"17","author":"Membreno","year":"2013","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.antiviral.2019.104620_bib35","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.jhep.2014.07.008","article-title":"Cyclophilin inhibition as potential therapy for liver diseases","volume":"61","author":"Naoumov","year":"2014","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.antiviral.2019.104620_bib36","doi-asserted-by":"crossref","first-page":"5279","DOI":"10.1128\/JVI.02631-07","article-title":"Proteomics analysis unravels the functional repertoire of coronavirus nonstructural protein 3 2","volume":"82","author":"Neuman","year":"2008","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2019.104620_bib37","doi-asserted-by":"crossref","first-page":"e888","DOI":"10.1038\/cddis.2013.410","article-title":"Cyclophilin A: a key player for human disease","volume":"4","author":"Nigro","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.antiviral.2019.104620_bib38","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nrmicro2147","article-title":"Coronaviruses post-SARS: update on replication and pathogenesis","volume":"7","author":"Perlman","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2019.104620_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002331","article-title":"The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors","volume":"7","author":"Pfefferle","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2019.104620_bib40","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/cbic.201200621","article-title":"Fine tuning the inhibition profile of cyclosporine A by derivatization of the MeBmt residue","volume":"14","author":"Prell","year":"2013","journal-title":"Chembiochem"},{"key":"10.1016\/j.antiviral.2019.104620_bib41","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1073\/pnas.91.9.3931","article-title":"Cyclophilin B trafficking through the secretory pathway is altered by binding of cyclosporin A","volume":"91","author":"Price","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2019.104620_bib42","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nature12005","article-title":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC","volume":"495","author":"Raj","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2019.104620_bib43","doi-asserted-by":"crossref","first-page":"466","DOI":"10.7164\/antibiotics.52.466","article-title":"Sanglifehrins A, B, C and D, novel cyclophilin-binding compounds isolated from Streptomyces sp. A92-308110. I. Taxonomy, fermentation, isolation and biological activity","volume":"52","author":"Sanglier","year":"1999","journal-title":"J.\u00a0Antibiot. (Tokyo)"},{"key":"10.1016\/j.antiviral.2019.104620_bib44","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1385\/IR:21:2-3:211","article-title":"Human immunodeficiency virus type 1 hijacks host cyclophilin A for its attachment to target cells","volume":"21","author":"Saphire","year":"2000","journal-title":"Immunol. Res."},{"key":"10.1016\/j.antiviral.2019.104620_bib45","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1128\/CVI.00355-10","article-title":"Differentiation between human coronaviruses NL63 and 229E using a novel double-antibody sandwich enzyme-linked immunosorbent assay based on specific monoclonal antibodies","volume":"18","author":"Sastre","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.antiviral.2019.104620_bib46","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1099\/jgv.0.000663","article-title":"Feline coronavirus replication is affected by both cyclophilin A and cyclophilin B","volume":"98","author":"Tanaka","year":"2017","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.antiviral.2019.104620_bib47","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.coviro.2015.08.004","article-title":"Genetic deficiency and polymorphisms of cyclophilin A reveal its essential role for Human Coronavirus 229E replication","volume":"14","author":"von Brunn","year":"2015","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.antiviral.2019.104620_bib48","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1053\/j.gastro.2012.04.053","article-title":"Hepatocytes that express variants of cyclophilin A are resistant to HCV infection and replication","volume":"143","author":"von Hahn","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2019.104620_bib49","series-title":"Synthesis of Cyclosporin H. US20120253007 A1","author":"Whitaker","year":"2011"},{"key":"10.1016\/j.antiviral.2019.104620_bib50","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.bbrc.2012.07.024","article-title":"Cyclophilin A and viral infections","volume":"424","author":"Zhou","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219303936?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219303936?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:30:56Z","timestamp":1759062656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354219303936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":50,"alternative-id":["S0166354219303936"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.104620","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influences of cyclosporin A and non-immunosuppressive derivatives on cellular cyclophilins and viral nucleocapsid protein during human coronavirus 229E replication","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.104620","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104620"}}